Neurology News

A Boston-area clinical stage drug discovery and development company announced $6 million in pre-Series B bridge financing to advance a novel cerebroprotectant therapeutic intended to treat a broad range of acute brain injuries.

Lumbar drainage following an aneurysmal subarachnoid hemorrhage was effective at reducing infarction and decreased rates of unfavorable neurological outcome at 6 months, according to data published in JAMA Neurology.

In dyads of Parkinson’s disease patients and caregivers, caregivers with a higher risk for depression were associated with patients’ lower quality of life and higher number of annual ED visits.

A California-based nonprofit and a biotechnology firm announced the activation of novel biologic ADI-PEG 20 in the GBM AGILE platform trial, a study that evaluates therapies for individuals with newly diagnosed or recurring glioblastoma.

A virtual reality therapy designed to ease anxiety associated with neuroimaging tests for patients with primary brain tumors appeared feasible, according to an interim analysis of a phase 2 clinical trial.

For individuals with relapsing-remitting multiple sclerosis, fatigue levels were associated with disability rate, physical conditioning and activity level, according to research from Multiple Sclerosis and Related Disorders.

Greater residential levels of fine particulate matter air pollution, especially from agriculture and wildfires, were linked to higher rates of dementia, according to study results published in JAMA Internal Medicine.

The FDA has approved once-daily Ingrezza capsules for adults with chorea associated with Huntington’s disease.

C2N Diagnostics released the PrecivityAD2 blood test, which uses positron emission tomography scans and cerebrospinal fluid tests to assist in accurate diagnosis for those presenting with signs or symptoms of Alzheimer’s disease.

An oral, extended-release therapeutic provided more ‘good’ on-time in fewer daily doses compared with immediate-release carbidopa/levodopa in Parkinson’s disease with motor fluctuations, according to research presented in JAMA Neurology.